Sarcopenia in Acute Ischemic Stroke
Sarcopenia in Patients During the Acute Phase of Ischemic Stroke: Multimodal Assessment and Three-Month Functional Outcomes
1 other identifier
observational
400
1 country
1
Brief Summary
The objective of this observational study is to determine the prevalence of sarcopenia in patients aged 50 years and older with acute ischemic stroke, to characterize its trajectory during the acute phase using instrumental verification and functional-cognitive assessments, and to evaluate its impact on functional outcome at three months. The main research question is: Is the presence of sarcopenia at admission associated with less favorable stroke outcomes, including higher rates of complications and mortality? Participants receiving standard medical care for acute ischemic stroke will undergo extended functional assessment for sarcopenia, and a subset will additionally undergo cognitive evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 4, 2026
CompletedFirst Posted
Study publicly available on registry
August 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
August 13, 2026
July 1, 2026
3.4 years
August 4, 2026
August 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from Baseline in Barthel Index for Activities of Daily Living at 14 days
Lower scores indicate increasing disability and a greater need for skilled care. Min - 0 ( \< 20 - totally dependent), max - 100 ( \> 80 - independent).
Baseline and 14 days
Change from Baseline in Modified Rankin scale at 90 days
Min - 0 (no disability), max - 6 (dead). A score of 0 is no disability, 5 is disability requiring constant care for all needs; 6 is death.
Baseline and 90 days
Secondary Outcomes (11)
Number of Participants with sarcopenia
Baseline
Change from Baseline in arm muscle mass at 14 and 28 days.
Baseline, 14 and 28 days
Change from Baseline in calf circumference at 14 and 28 days
Baseline, 14 and 28 days
Change from Baseline in handgrip strength at 14 and 28 days.
Baseline, 14 and 28 days.
Correlations between anthropometric measures and ultrasound/CT parameters
Baseline, 14, 28, and 90 days
- +6 more secondary outcomes
Eligibility Criteria
The study population comprises patients with acute ischemic stroke admitted within the first 72 hours after symptom onset.
You may qualify if:
- Age 50 years and older
- Acute ischemic stroke confirmed by CT or MRI
- Admission within the first 72 hours
- Written informed consent and availability of a contact telephone number for follow-up
You may not qualify if:
- TIA without a visible lesion on neuroimaging; bilateral hemiparesis
- Amputations or severe contractures that preclude anthropometric assessment
- Active cancer at stage IV or life expectancy of less than 3 months
- Neuromuscular diseases; chronic use of systemic glucocorticoids for more than 3 months
- Pregnancy; refusal to participate
- Discontinuation criteria (drop-out)
- Discharge or death within the first 7 days
- Withdrawal of consent
- Transfer to another facility resulting in loss of contact
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moscow State Budgetary Healthcare Institution "Moscow City Hospital named after S.S. Yudin, Moscow Healthcare Department"
Moscow, 115446, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2026
First Posted
August 13, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
August 13, 2026
Record last verified: 2026-07